Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway

Forum on Immunopathological Diseases and Therapeutics - United States
doi 10.1615/forumimmundisther.2015014188
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Begell House

Related search

OX40- And CD27-Mediated Costimulation Synergizes With Anti–PD-L1 Blockade by Forcing Exhausted CD8+T Cells to Exit Quiescence

Journal of Immunology
AllergyImmunology
2014English

Specific Blockade CD73 Alters the ‘Exhausted' Phenotype of T Cells in Head and Neck Squamous Cell Carcinoma

International Journal of Cancer
Cancer ResearchOncology
2018English

Suppression of IL-22–Producing T Helper 22 Cells by RPE Cells via PD-L1/PD-1 Interactions

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2013English

Distinct Prognostic Value of Circulating Anti-Telomerase CD4+ Th1 Immunity and Exhausted PD-1+/TIM-3+ T Cells in Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

Targeting the mTOR Pathway Uncouples the Efficacy and Toxicity of PD-1 Blockade in Renal Transplantation

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Improved Survival of CAR‐T and Tumor‐specific T Cells Caused by Anti‐PD‐1 scFv‐producing CAR‐T Cells

Cancer Science
Cancer ResearchMedicineOncology
2019English

Epitherapy and Immune Checkpoint Blockade: Using Epigenetic Reinvigoration of Exhausted and Dysfunctional T Cells to Reimburse Immunotherapy Response

BMC Immunology
Immunology
2020English

The PD-1/PD-L1 (B7-H1) Pathway in Chronic Infection-Induced Cytotoxic T Lymphocyte Exhaustion

Journal of Biomedicine and Biotechnology
2011English

Exosomes Derived From Exhausted CD8+ T Cells Impaired the Anticancer Function of Normal CD8+ T Cells

Journal of Medical Genetics
Genetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy